FDA Inspection 1203902 — Advanced Reproductive Center of Hawaii

Advanced Reproductive Center of Hawaii — FEI 3005208550

The FDA completed an inspection of Advanced Reproductive Center of Hawaii on April 28, 2023 in Honolulu, HI. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). 1 citation was issued during this inspection. Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
April 28, 2023
Fiscal Year
2023
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Honolulu, HI (United States)

Citations

IDCFRDescription
1227721 CFR 1271.75(a)(1)Risk factors, clinical evidence